GLICLAZIDA ZENTIVA 60mg modified release tablets medication leaflet

A10BB09 gliclazide • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Gliclazide is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin, thereby helping to lower blood sugar levels.

It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Gliclazide is effective in preventing diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).

Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, dizziness, or weight gain. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.

General data about GLICLAZIDA ZENTIVA 60mg

Substance: gliclazide

Date of last drug list: 01-12-2021

Commercial code: W61093002

Concentration: 60mg

Pharmaceutical form: modified release tablets

Quantity: 90

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ZENTIVA S.A. - ROMANIA

Holder: ZENTIVA, K.S. - REPUBLICA CEHA

Number: 12146/2019/02

Shelf life: 3 years

Pharmaceutical forms available for gliclazide

Concentrations available for gliclazide

30mg, 60mg, 80mg, 90mg